Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04891107 · ClinicalTrials.gov registry record · NA
Feasibility and Preliminary Effects of MR-005 in Persons With Parkinson Disease
A NA study, sponsored by MedRhythms.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT04891107: Completed NA study, sponsored by MedRhythms.
NCT04891107 is a NA study that has completed, run by MedRhythms. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04891107, a NA study, has completed, sponsored by MedRhythms.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to evaluate the effects of music, tailored to the participant's cadence, on adherence, quality of life, gait speed, functional mobility, and walking activity in individuals with Parkinson disease when used in the home and community environment.
Primary Outcome
Percentage of scheduled sessions completed (5 times per week for 4 weeks)
Interventions
- DEVICE Walking Program with a Music-based, Rhythm-modulating Wearable Sensor System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2021-07-02 |
| Est. Completion | 2022-06-08 |
| Phase | NA |
What the finished NCT04891107 record still lists
NCT04891107 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Walking Program with a Music-based, Rhythm-modulating Wearable Sensor System is the first listed.
NCT04891107 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04891107 about?
NCT04891107 is a clinical study titled "Feasibility and Preliminary Effects of MR-005 in Persons With Parkinson Disease". The purpose of this clinical study is to evaluate the effects of music, tailored to the participant's cadence, on adherence, quality of life, gait speed, functional mobility, and walking activity in individuals with Parkinson disease when used in the home and community environment.
What is the current status of trial NCT04891107?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2021-07-02. Estimated completion is 2022-06-08.
What interventions are being tested in trial NCT04891107?
The interventions under investigation include: Walking Program with a Music-based, Rhythm-modulating Wearable Sensor System (DEVICE).
Who is sponsoring clinical trial NCT04891107?
This trial is sponsored by MedRhythms, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04891107's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI